Badivuku S, Pavlovic M, Plavec D, Turk R
Instituto de Investigación Médica y Medicina Laboral, Zagreb, Croacia.
Rev Med Chil. 1995 Aug;123(8):967-73.
Bronchial reactivity to methacholine was examined in three groups of smokers (N = 93): subjects with secondary inactive pulmonary tuberculosis (TPI) 2 years after the beginning of treatment (N = 44); subjects with asymptomatic chronic bronchitis (N = 25) and healthy control (N = 24). Mean PC20FEV1 was 9.54 (SD 6.05), 11.12 (SD 5.42) and 13.74 (SD 4.7) respectively (tuberculosis vs control, p < 0.02). According to the arbitrary criteria for bronchial asthma, nonspecific hyperreactivity was present in 50% of subjects with TPI, in 37.5% of bronchitic patients and in 16% of control subjects. No difference was found with regard to PC20FEV1, the chemotherapeutic regimen (9 or 12 months of therapy), results of tuberculin test (normo and hyperreactive) and X-ray findings determined before the onset of treatment. Mahalanobis statistical analysis with respect to smoking index, basal ventilatory function tests and nonspecific bronchial reactivity grouped together healthy volunteers and subjects with a history of pulmonary tuberculosis apart from the group with asymptomatic chronic bronchitis.
对三组吸烟者(N = 93)进行了乙酰甲胆碱支气管反应性检测:治疗开始2年后的继发性非活动性肺结核(TPI)患者(N = 44);无症状慢性支气管炎患者(N = 25)和健康对照者(N = 24)。平均PC20FEV1分别为9.54(标准差6.05)、11.12(标准差5.42)和13.74(标准差4.7)(肺结核组与对照组比较,p < 0.02)。根据支气管哮喘的任意标准,50%的TPI患者、37.5%的支气管炎患者和16%的对照者存在非特异性高反应性。在PC20FEV1、化疗方案(9或12个月治疗)、治疗开始前结核菌素试验结果(正常和高反应性)及X线表现方面未发现差异。将吸烟指数、基础通气功能试验和非特异性支气管反应性进行马氏统计分析,结果显示健康志愿者和有肺结核病史的受试者与无症状慢性支气管炎组区分开来。